Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Fuller

Showing results (141-150 of 163) with videos related to

Pageof 17
Sort By:
Diabetes|March 15, 2001
Lipid transfer protein activities in type 1 diabetic patients without renal failure and nondiabetic control subjects and their association with coronary artery calcificationH M Colhoun, L M Scheek, M B Rubens, et al.
Diabetologia|February 3, 2009
Levels of soluble receptor for AGE are cross-sectionally associated with cardiovascular disease in type 1 diabetes, and this association is partially mediated by endothelial and renal dysfunction and by low-grade inflammation: the EURODIAB Prospective Complications StudyJ W M Nin, I Ferreira, C G Schalkwijk, et al.
Diabetologia|October 12, 2012
Association of physical activity with all-cause mortality and incident and prevalent cardiovascular disease among patients with type 1 diabetes: the EURODIAB Prospective Complications StudyS M A J Tielemans, S S Soedamah-Muthu, M De Neve, et al.
Acta Diabetologica|June 22, 2017
Incidence of prolonged QTc and severe hypoglycemia in type 1 diabetes: the EURODIAB Prospective Complications StudyCristina Amione, Sara Giunti, Paolo Fornengo, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 13, 2001
Plasma lipids and urinary albumin excretion rate in Type 1 diabetes mellitus: the EURODIAB IDDM Complications StudyM B Mattock, N Cronin, P Cavallo-Perin, et al.
Diabetologia|October 6, 2001
Risk factors for renal failure: the WHO Mulinational Study of Vascular Disease in DiabetesH M Colhoun, E T Lee, P H Bennett, et al.
European Journal of Clinical Nutrition|July 16, 2015
Association of diet and lifestyle with glycated haemoglobin in type 1 diabetes participants in the EURODIAB prospective complications studyS N Balk, D A J M Schoenaker, G D Mishra, et al.
Diabetologia|November 1, 1996
Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications StudyS Tesfaye, L K Stevens, J M Stephenson, et al.
Journal of Internal Medicine|July 1, 2009
ANTI-HSP60 and ANTI-HSP70 antibody levels and micro/ macrovascular complications in type 1 diabetes: the EURODIAB StudyG Gruden, G Bruno, N Chaturvedi, et al.
Archives of Physiology and Biochemistry|March 7, 2002
Blood pressure response to standing in the diagnosis of autonomic neuropathy: the EURODIAB IDDM Complications StudyP Kempler, S Tesfaye, N Chaturvedi, et al.
Pageof 17

Showing results (141-150 of 163) with videos related to

Sort By:
Pageof 17
Diabetes|March 15, 2001
Lipid transfer protein activities in type 1 diabetic patients without renal failure and nondiabetic control subjects and their association with coronary artery calcificationH M Colhoun, L M Scheek, M B Rubens, et al.
Diabetologia|February 3, 2009
Levels of soluble receptor for AGE are cross-sectionally associated with cardiovascular disease in type 1 diabetes, and this association is partially mediated by endothelial and renal dysfunction and by low-grade inflammation: the EURODIAB Prospective Complications StudyJ W M Nin, I Ferreira, C G Schalkwijk, et al.
Diabetologia|October 12, 2012
Association of physical activity with all-cause mortality and incident and prevalent cardiovascular disease among patients with type 1 diabetes: the EURODIAB Prospective Complications StudyS M A J Tielemans, S S Soedamah-Muthu, M De Neve, et al.
Acta Diabetologica|June 22, 2017
Incidence of prolonged QTc and severe hypoglycemia in type 1 diabetes: the EURODIAB Prospective Complications StudyCristina Amione, Sara Giunti, Paolo Fornengo, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 13, 2001
Plasma lipids and urinary albumin excretion rate in Type 1 diabetes mellitus: the EURODIAB IDDM Complications StudyM B Mattock, N Cronin, P Cavallo-Perin, et al.
Diabetologia|October 6, 2001
Risk factors for renal failure: the WHO Mulinational Study of Vascular Disease in DiabetesH M Colhoun, E T Lee, P H Bennett, et al.
European Journal of Clinical Nutrition|July 16, 2015
Association of diet and lifestyle with glycated haemoglobin in type 1 diabetes participants in the EURODIAB prospective complications studyS N Balk, D A J M Schoenaker, G D Mishra, et al.
Diabetologia|November 1, 1996
Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications StudyS Tesfaye, L K Stevens, J M Stephenson, et al.
Journal of Internal Medicine|July 1, 2009
ANTI-HSP60 and ANTI-HSP70 antibody levels and micro/ macrovascular complications in type 1 diabetes: the EURODIAB StudyG Gruden, G Bruno, N Chaturvedi, et al.
Archives of Physiology and Biochemistry|March 7, 2002
Blood pressure response to standing in the diagnosis of autonomic neuropathy: the EURODIAB IDDM Complications StudyP Kempler, S Tesfaye, N Chaturvedi, et al.
Pageof 17